Yes, good morning. Just wanted to check, I know you mentioned on the pricing. To give a sense of the pricing of Revlimid in the U.S., how is it feeling right now? That's one. And second, you said one third of the market share. What would be a tentative market share right now for us in the Revlimid in the U.S. market?
Okay. And any sense on the competitive landscape right now, how many players are there?